Health Professionals
The information in this section is for health providers, such as doctors, pharmacists, nurses, medical assistants, etc. and not present as medical advice to health professionals.
Safety Alerts & NPRA Recent Updates
Safety Updates on COVID-19 Vaccine (Comirnaty®) |
Mesalazine and sulfasalazine: Nephrolithiasis |
Efavirenz (including combination products): Risk of late onset neurotoxicity |
Oseltamivir: Thrombocytopenia |
Clozapine: Risk of serious bowel complications caused by constipation |
Reporting ADR/AEFI by Healthcare Professionals
Please report ALL suspected Adverse Drug Reactions (ADRs) (including those for traditional products) and Adverse Events Following Immunisation (AEFIs) to the National Centre for Adverse Drug Reactions Monitoring.
Do not hesitate to report if some details are not known.The identities of Reporter, Patient and Institution will remain confidential.
Quality Reporting
Please use this form to report for quality reporting of registered product (e.g. quality, efficacy, labelling, packaging) NOT related to ADRs.
Products Search
Search Pharmaceutical, Complimentary & Alternative Products that registered with National Pharmaceutical Regulatory Agency, NPRA. You may also search cosmetic products notified with NPRA
NEWSLETTER: MADRAC BULLETIN
REAKSI DRUG SAFETY NEWS
awareness of adverse drug reactions reported, and stimulate additional adverse drug reaction reporting.
Consumer Information

Online Public Engagement
